 |


Audit Experience:
Hamari has been audited between 2005-2007, by:
• World’s top 20 pharmaceutical companies = 11 times
• Japan’s
top 20 pharmaceutical companies = 16 times
• Others, such as the FDA
= 5 times
Clinical Trial Experience:
We have had clinical trials between 2005-2007, by:
• World’s top 20 pharmaceutical companies = 13 times
• Japan’s
top 20 pharmaceutical companies = 21 times
• Others, such as the FDA
= 14 times
Awards:
• Received “Ishii Devise Merits Prize” from JSAI
(Japan Society for advancement of Inventions) for the discovery of
Polaprezinc (against peptic ulcer) in 2001
• Nominated as the “Product of Year” in 2003 by
Nutracon
• Nominated as the “Product of Year” in 2004 by
Nutracon
|
 |
|
|